A team of researchers have identified the cause of resistance to breakthrough breast and ovarian cancer drugs.
Browsing: Disease Area > Gynecologic
Discover details of the first randomized, multicenter Phase III study to compare the safety and efficacy of mirvetuximab soravtansine vs investigator’s choice of chemotherapy in women with folate receptor-α-positive, platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancer.
Discover the case of a heavily pretreated patient with recurrent advanced squamous cell carcinoma of the cervix who had exhausted all available treatments and demonstrated a striking response to pembrolizumab.
Blueberry extract has been shown to improve success rate of radiation therapy in patients with cervical cancer.
Researchers from the Case Western Reserve University (OH, USA) have demonstrated how a computer program can suggest novel cancer treatments.
A new study has demonstrated that women may only need three cervical screens in their lifetime if they have received the HPV vaccine.
Among other criteria, in this research article from Future Science OA, the authors validated the Gynecological Cancer Intergroup CA125 progression criteria in an ovarian cancer population regarding sensitivity, specificity, positive predictive value and negative predictive value.
In this perspective paper, discover three pictorial models that are designed to help offer patients focus and belief when combating cancer in their lives to allow them to embrace hope with greater confidence, which minimizes their grief.